Vadim Dudkin, PhD

Founding Chief Technology Officer at Soufflé Therapeutics

Speaker

As the Founding Chief Technology Officer, at Soufflé Therapeutics, Vadim leads research, discovery and development to translate breakthroughs into medicines for patients.

Bringing more than 20 years of experience, Vadim has led multiple platform and biology teams focusing on nucleic acids, small molecules, and radiopharmaceuticals which have contributed to numerous development and clinical candidates. He previously served as Founder and Global Head of RNA and Targeted Therapeutics at Johnson and Johnson (J&J), with worldwide platform responsibility for RNA medicines, protein conjugates, ADCs and the targeted nanotherapies discovery portfolio. Prior to this, Vadim led an internal venture research team at J&J that established a universal protein targeting platform, contributing to the creation of Poseida, Fusion, and Aro Biotherapeutics. Vadim began his career at Merck, where he held roles of increasing responsibility, eventually leading a team focused on siRNA conjugate research.

Vadim earned his PhD from University of Illinois and completed his postdoctoral training at Memorial Sloan Kettering Cancer Center.